Primer in Genetics and Genomics,Article 6: Basics of Epigenetic Control

Abstract

The epigenome is a collection of chemical compounds that attach to and overlay the DNA sequence to direct gene expression. Epigenetic marks do not alter DNA sequence but instead allow or silence gene activity and the subsequent production of proteins that guide the growth and development of an organism, direct and maintain cell identity, and allow for the production of primordial germ cells (PGCs; ova and spermatozoa). The three main epigenetic marks are (1) histone modification, (2) DNA methylation, and (3) noncoding RNA, and each works in a different way to regulate gene expression. This article reviews these concepts and discusses their role in normal functions such as X-chromosome inactivation, epigenetic reprogramming during embryonic development and PGC production, and the clinical example of the imprinting disorders Angelman and Prader–Willi syndromes.

Keywords

epigenomics histone code chromatin DNA methylation X-chromosome inactivation

Get full access to this article

View all access options for this article.

References

Allis

C. D.

Jenuwein

(2016). The molecular hallmarks of epigenetic control. Nature Reviews Genetics, 17, 487–500.

Barlow

D. P.

Bartolomei

M. S.

(2014). Genomic imprinting in mammals. Cold Spring Harbor Perspectives in Biology, 6. doi:10.1101/cshperspect.a018382

Barr

M. L.

Bertram

E. G.

(1949). A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature, 163, 676.

Cassidy

S. B.

Dykens

Williams

C. A

. (2000). Prader-Willi and Angelman syndromes: Sister imprinted disorders. American Journal of Medical Genetics, 97, 136–146. doi:10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V

Clayton-Smith

Laan

(2003). Angelman syndrome: A review of the clinical and genetic aspects. Journal of Medical Genetics, 40, 87–95.

Dawson

M. A.

Kouzarides

(2012). Cancer epigenetics: From mechanism to therapy. Cell, 150, 12–27.

Deichmann

(2016). Epigenetics: The origins and evolution of a fashionable topic. Developmental Biology, 416, 249–254.

Dey

B. K.

Mueller

A. C.

Dutta

(2014). Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription, 5, e944014.

Disteche

C. M.

Berletch

J. B.

(2015). X-chromosome inactivation and escape. Journal of Genetics, 94, 591–599.

10.

Dorman

J. S.

Schmella

M. J.

Wesmiller

S. W.

(2016). Primer in genetics and genomics, Article 1—DNA, genes, and chromosomes. Biological Research for Nursing, 19, 7–17.

11.

Duarte

J. D.

(2013). Epigenetics primer: Why the clinician should care about epigenetics. Pharmacotherapy, 33, 1362–1368. doi:10.1002/phar.1325

12.

Eisenberg

Levanon

E. Y.

(2013). Human housekeeping genes, revisited. Trends in Genetics, 29, 569–574.

13.

Felsenfeld

(2014). A brief history of epigenetics. Cold Spring Harbor Perspectives in Biology, 6, a018200. doi:10.1101/cshperspect.a018200

14.

Gayon

(2016). From Mendel to epigenetics: History of genetics. Comptes Rendus Biologies, 339, 225–230. doi:10.1016/j.crvi.2016.05.009

15.

Gunay-Aygun

Schwartz

Heeger

O’Riordan

M. A.

Cassidy

S. B.

(2001). The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics, 108, E92. doi:10.1542/peds.108.5.e92

16.

Hua

Lee

Liu

Keep

R. F.

Wang

M. M.

(2010). Brain alpha- and beta-globin expression after intracerebral hemorrhage. Translational Stroke Research, 1, 48–56. doi:10.1007/s12975-009-0004-x

17.

Hill

M. A.

(2017). Gastrulation. Embryology. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Gastrulation

18.

Holliday

(2006). Epigenetics: A historical overview. Epigenetics, 1, 76–80.

19.

Horsthemke

(2014). In brief: Genomic imprinting and imprinting diseases. Journal of Pathology, 232, 485–487.

20.

Inbar-Feigenberg

Choufani

Butcher

D. T.

Roifman

Weksberg

(2013). Basic concepts of epigenetics. Fertility and Sterility, 99, 607–615. doi:10.1016/j.fertnstert.2013.01.117

21.

Irizarry

K. A.

Miller

Freemark

Haqq

A. M.

(2016). Prader Willi syndrome: Genetics, metabolomics, hormonal function, and new approaches to therapy. Advances in Pediatrics, 63, 47–77. doi:10.1016/j.yapd.2016.04.005

22.

Jang

H. S.

Shin

W. J.

Lee

J. E.

J. T.

(2017). CpG and non-CpG methylation in epigenetic gene regulation and brain function. Genes, 8, 148. doi:10.3390/genes8060148

23.

Kim

Samaranayake

Pradhan

(2009). Epigenetic mechanisms in mammals. Cellular and Molecular Life Sciences, 66, 596.

24.

Kota

S. K.

Feil

(2010). Epigenetic transitions in germ cell development and meiosis. Developmental Cell, 19, 675–686.

25.

Kovalchuk

(2012). Epigenetics in health and disease. Upper Saddle River, NJ: FT Press.

26.

LeMieux

. (2017). Calico cats are a walking genetics lesson. Retrieved from the American Council on Science and Health at https://www.acsh.org/news/2016/07/27/calico-cats-are-a-walking-genetics-lesson

27.

Lyon

M. F.

(1961). Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature, 190, 372–373. doi:10.1038/190372a0

28.

Lyon

M. F.

(2005). X chromosome inactivation: No longer all-or-none’. European Journal of Human Genetics: EJHG, 13, 796–797.

29.

Nanney

D. L.

(1958). Epigenetic control systems. Proceedings of the National Academy of Sciences of the United States of America, 44, 712–717.

30.

National Human Genome Research Institute. (2016). Epigenomics fact sheet. Retrieved from https://www.genome.gov/27532724/

31.

Ohno

Kaplan

Kinosita

(1959). Formation of the sex chromatin by a single X-chromosome in liver cells of Rattus norvegicus . Experimental Cell Research, 18, 415–418.

32.

Online Mendelian Inheritance in Man. (2017). Ubiquitin-protein ligase e3a; ube3a. Retrieved from https://www.omim.org/entry/601623

33.

Ozcan

Ozpolat

Coleman

R. L.

Sood

A. K.

Lopez-Berestein

(2015). Preclinical and clinical development of siRNA-based therapeutics. Advanced Drug Delivery Reviews, 87, 108–119. doi:10.1016/j.addr.2015.01.007

34.

Patil

V. S.

Zhou

Rana

T. M.

(2014). Gene regulation by non-coding RNAs. Critical Reviews in Biochemistry and Molecular Biology, 49, 16–32.

35.

Peters

(2014). The role of genomic imprinting in biology and disease: An expanding view. Nature Reviews Genetics, 15, 517.

36.

Phillips

Hoopes

(2008). Transcription factors and transcriptional control in eukaryotic cells. Nature Education, 1, 119.

37.

Rasmussen

K. D.

Helin

(2016). Role of TET enzymes in DNA methylation, development, and cancer. Genes & Development, 30, 733–750. doi:10.1101/gad.276568.115

38.

Rodenhiser

Mann

(2006). Epigenetics and human disease: Translating basic biology into clinical applications. CMAJ: Canadian Medical Association Journal, 174, 341–348. doi:10.1503/cmaj.050774

39.

Rothbart

S. B.

Strahl

B. D.

(2014). Interpreting the language of histone and DNA modifications. Biochimica et Biophysica Acta, 1839, 627–643.

40.

Sato

(2017). Early origin and evolution of the Angelman syndrome ubiquitin ligase gene Ube3a. Frontiers in Cellular Neuroscience, 11, 62. doi:10.3389/fncel.2017.00062

41.

Schübeler

(2015). Function and information content of DNA methylation. Nature, 517, 321–326. doi:10.1038/nature14192

42.

Seisenberger

Peat

J. R.

Hore

T. A.

Santos

Dean

Reik

(2013). Reprogramming DNA methylation in the mammalian life cycle: Building and breaking epigenetic barriers. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 368, 20110330. doi:10.1098/rstb.2011.0330

43.

Sha

Boyer

L. A

(2009). The chromatin signature of pluripotent cells. In The Stem Cell Research Community (Ed.), StemBook. Retrieved from http://www.stembook.org/node/585.

44.

She

Rohl

C. A.

Castle

J. C.

Kulkarni

A. V.

Johnson

J. M.

Chen

(2009). Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics, 10, 269.

45.

Stochholm

Juul

Gravholt

C. H.

(2010). Mortality and incidence in women with 47, XXX and variants. American Journal of Medical Genetics Part A, 152, 367–372.

46.

Swerdlow

A. J.

Higgins

C. D.

Schoemaker

M. J.

Wright

A. F.

Jacobs

P. A.

(2005). Mortality in patients with Klinefelter syndrome in Britain: A cohort study. Journal of Clinical Endocrinology & Metabolism, 90, 6516–6522.

47.

Swerdlow

A. J.

Schoemaker

M. J.

Higgins

C. D.

Wright

A. F.

Jacobs

P. A.

(2005). Mortality and cancer incidence in women with extra X chromosomes: A cohort study in Britain. Human Genetics, 118, 255–260.

48.

Tan

Bacino

C. A.

Skinner

S. A.

Anselm

Barbieri-Welge

Bauer-Carlin

… Glaze

D. G

(2011). Angelman syndrome: Mutations influence features in early childhood. American Journal of Medical Genetics Part A, 155, 81–90.

49.

Trerotola

Relli

Simeone

Alberti

(2015). Epigenetic inheritance and the missing heritability. Human Genomics, 9, 17.

50.

U.S. National Library of Medicine. (2017). HBB gene. In Genetics home reference. Retrieved from https://ghr.nlm.nih.gov/gene/HBB

51.

Waddington

C. H.

(1942). Canalization of development and the inheritance of acquired characters. Nature, 150, 563–565.

52.

Williams

C. A.

Driscoll

D. J.

Dagli

A. I.

(2010). Clinical and genetic aspects of Angelman syndrome. Genetics in Medicine, 12, 385–395.

53.

Sun

Y. E.

(2006). Epigenetic regulation of stem cell differentiation. Pediatric Research, 59, 21R–25R.

54.

Yang

Chapman

A. G.

Kelsey

A. D.

Minks

Cotton

A. M.

Brown

C. J.

(2011). X-chromosome inactivation: Molecular mechanisms from the human perspective. Human Genetics, 130, 175–185.

55.

Zitzmann

Bongers

Werler

Bogdanova

Wistuba

Kliesch

… Tüttelmann

(2015). Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome. Journal of Clinical Endocrinology & Metabolism, 100, E518–E523.